SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 26.63 CNY | -1.92% |
|
-2.77% | -18.46% |
| 05-22 | Salubris Pharmaceuticals Gets Nod to Market Hypertension Drug | MT |
| 04-23 | Salubris Pharmaceuticals' Q1 Profit Falls 5% Despite 23% Rise in Operating Income | MT |
Evolution of the average Target Price on Shenzhen Salubris Pharmaceuticals Co., Ltd.
Price target over the last 5 years
History of analyst recommendation changes
f0e0f747d0dae1de1b0b233.lgMqDM-J_SyOsICJv98tzDCY04d4fQCVrqBIZGiFwko.-XteY7i8kXa-3-LG0YtUh2WoquE5JTndwJgEKh__mHjccxJlncKLHd_CyQ~e66d982984ccb27c04bcb6b1b59a4df1
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
26.63
CNY
Average target price
37
CNY
Spread / Average Target
+38.94%
High Price Target
41
CNY
Spread / Highest target
+53.96%
Low Price Target
33
CNY
Spread / Lowest Target
+23.92%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
D+
EPS Revisions
- Stock Market
- Equities
- 002294 Stock
- Consensus Shenzhen Salubris Pharmaceuticals Co., Ltd.
